We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+21.79%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.16B
AUM Growth
+$372M
Cap. Flow
+$132M
Cap. Flow %
11.39%
Top 10 Hldgs %
68.38%
Holding
232
New
129
Increased
24
Reduced
12
Closed
56

Top Buys

Rank Stock Value
1
SANA icon
Sana Biotechnology
SANA
+$72.8M
2
PBR.A icon
Petrobras Class A
PBR.A
+$20.9M
3
AMP icon
Ameriprise Financial
AMP
+$11.4M
4
MET icon
MetLife
MET
+$10.1M
5
WFC icon
Wells Fargo
WFC
+$7.59M

Top Sells

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$114M
2
MU icon
Micron Technology
MU
+$7.77M
3
UDR icon
UDR
UDR
+$5.92M
4
EQH icon
Equitable Holdings
EQH
+$4.95M
5
LRCX icon
Lam Research
LRCX
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 61.94%
2 Financials 15.05%
3 Materials 5.33%
4 Technology 3.84%
5 Energy 2.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSI
151
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
$202K 0.02%
+21,012
New +$203K
PGRW
152
DELISTED
Progress Acquisition Corp. Class A Common Stock
PGRW
$199K 0.02%
+20,490
New +$200K
GLS
153
DELISTED
Gelesis Holdings, Inc.
GLS
$165K 0.01%
16,902
-2,146
-11% -$21.1K
ADN
154
CALL
DELISTED
Advent Technologies
ADN
$121K 0.01%
+417
New +$139K
DNZ
155
DELISTED
D and Z Media Acquisition Corp.
DNZ
$107K 0.01%
+10,999
New +$108K
PDYN icon
156
Palladyne AI
PDYN
$247M
$100K 0.01%
+1,667
New +$99.2K
HCAR
157
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$100K 0.01%
+10,300
New +$100K
PMVC
158
DELISTED
PMV Consumer Acquisition Corp.
PMVC
$100K 0.01%
+10,246
New +$100K
AILE
159
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$100K 0.01%
+10,400
New +$101K
BITE
160
DELISTED
Bite Acquisition Corp.
BITE
$100K 0.01%
+10,300
New +$99.9K
JOFF
161
DELISTED
JOFF Fintech Acquisition Corp. Class A Common Stock
JOFF
$99K 0.01%
+10,300
New +$100K
BLTS
162
DELISTED
Bright Lights Acquisition Corp. Class A Common Stock
BLTS
$99K 0.01%
+10,241
New +$99.7K
FOA icon
163
CALL
Finance of America Companies
FOA
$203M
$76K 0.01%
+1,000
New +$96.8K
KSICW
164
DELISTED
Kadem Sustainable Impact Corporation Warrant
KSICW
$8K ﹤0.01%
+10,506
New +$7.22K
WARR.WS
165
DELISTED
Warrior Technologies Acquisition Company Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
WARR.WS
$7K ﹤0.01%
+9,600
New +$5.83K
AAPL icon
166
Apple
AAPL
$4.54T
-22,500
Closed -$2.75M
AAPL icon
167
PUT
Apple
AAPL
$4.54T
-9,000
Closed -$1.1M
ABNB icon
168
Airbnb
ABNB
$89.9B
-1,600
Closed -$301K
ABNB icon
169
PUT
Airbnb
ABNB
$89.9B
-1,600
Closed -$301K
ADBE icon
170
Adobe
ADBE
$99.5B
-2,920
Closed -$1.39M
ADBE icon
171
PUT
Adobe
ADBE
$99.5B
-600
Closed -$285K
AJG icon
172
Arthur J. Gallagher & Co
AJG
$64.1B
-30,259
Closed -$3.77M
AMAT icon
173
Applied Materials
AMAT
$403B
-21,156
Closed -$2.83M
AMT icon
174
American Tower
AMT
$80.8B
-3,000
Closed -$717K
AMZN icon
175
PUT
Amazon
AMZN
$2.92T
-2,000
Closed -$309K

Similar funds

Crestline Management's Q2 2021 Portfolio in Review

As of Q2 2021, Crestline Management held 232 positions worth $1.16B, up 47% from $788M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Crestline Management deployed $132M of net new capital in Q2 2021, opening 129 new positions and adding to 24 existing holdings. Its largest new stake was Sana Biotechnology: 3,210,937 shares worth $63.1M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 72% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Denali Therapeutics, an estimated $114M trimmed.

  • Crestline Management's largest Q2 2021 buy was Sana Biotechnology: 3,210,937 shares worth $63.1M.
  • Crestline Management added most to Travelers Companies in Q2 2021, an estimated $6.82M increase.
  • Crestline Management's biggest Q2 2021 reduction was Denali Therapeutics, cutting an estimated $114M.
  • Crestline Management fully exited Micron Technology in Q2 2021, selling an estimated $7.77M.
  • Crestline Management's ten largest holdings make up 68% of its $1.16B portfolio in Q2 2021.
  • Crestline Management opened 129 new positions and closed 56 in Q2 2021.
  • Crestline Management's portfolio value rose 47% quarter-over-quarter to $1.16B.

Based on Crestline Management's 13F filing for Q2 2021, filed 13 Aug 2021.